Search for: "In re: DARVOCET, DARVON, AND PROPOXYPHENE PRODUCTS LIABILITY LITIGATION" Results 21 - 31 of 31
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Jun 2012, 2:23 pm by Bexis
  See In re Darvocet, Darvon & Propoxyphene Products Liability Litigation, MDL No. 2226, slip op. [read post]
16 May 2012, 12:22 pm by Bexis
Feb. 15, 2012).Failure to update warning claims TwIqballed for failure to plead any facts to support the claim.In re Darvocet, Darvon and Propoxyphene Products Liability Litigation, 2012 WL 718618, at *4 (E.D. [read post]
15 May 2012, 11:26 am by Michelle Yeary
  In re: Darvocet, Darvon and Propoxyphene Products Liability Litigation, MDL Docket No. 2226 (E.D. [read post]
7 May 2012, 5:00 am by Bexis
Sherwood Medical Industries, 836 F.2d 296, 302-303 (7th Cir. 1987); In re Zyprexa Products Liability Litigation v. [read post]
10 Apr 2012, 2:33 pm by Carlee Hobbs Toth
No briefing schedule has been set, but we will update you as In re: Darvocet, Darvon and Propoxyphene Products Liability Litigation, Case No. 12-5368 goes forward.  [read post]
10 Apr 2012, 2:33 pm by Carlee Hobbs Toth
  No briefing schedule has been set, but we will update you as In re: Darvocet, Darvon and Propoxyphene Products Liability Litigation, Case No. 12-5368 goes forward. [read post]
5 Apr 2012, 11:54 am by Bexis
March 28, 2012) (including fraudulent concealment); In re Darvocet, Darvon & Propoxyphene Products Liability Litigation, 2012 WL 718618, at *5 (E.D. [read post]
20 Mar 2012, 7:00 am by Bexis
  In In re Darvocet, Darvon & Propoxyphene Products Liability Litigation, 2012 WL 767595 (E.D. [read post]
8 Mar 2012, 10:08 am by Bexis
In In re Darvocet, Darvon & Propoxyphene Products Liability Litigation, MDL No. 2226, slip op. [read post]
14 Feb 2012, 11:50 am by Michelle Yeary
Combination Aspirin Products Marketing and Sales Practices Litigation (no website)MDL - 2051 IN RE: Denture Cream Products Liability Litigation MDL - 2066 IN RE: Oral Sodium Phosphate Solution-Based Products Liability Litigation MDL - 2067 IN RE: Celexa and Lexapro Marketing and Sales Practices Litigation (no website)MDL - 2087 IN RE: Hydroxycut Marketing and Sales Practices… [read post]